2 results
Approved WMORecruiting
The objective of the current study is to investigate the efficacy, safety and tolerability of linagliptin (5 mg / once daily) compared to placebo given for 24 weeks as add-on therapy to stable treatment in elderly patients with diabetes mellitus…
Approved WMOCompleted
To investigate the safety and tolerability, and to characterise the pharmacokinetics (PK) of RGH-338 in healthy subjects